English

American Renal Associates Holdings, Inc.

EDGAR

ARA Quarterly report (10-Q) · filed 2020-11-06

23 filing records in this dataset, filed from 2015-08-31 to 2020-11-06. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

210 million USD

2020 Q3 · USD

Exact inputs and evidence

Revenue: 209689000 USD Source

Operating margin

9.67%

2020 Q3 · %

Exact inputs and evidence

Operating Income: 20274000 USD Source
Revenue: 209689000 USD Source

Operating cash flow

19.5 million USD

2020 Q3 · USD

Exact inputs and evidence

Operating Cash Flow: 170435000 USD Source
Operating Cash Flow: 150962000 USD Source

Free cash flow

15.4 million USD

2020 Q3 · USD

Exact inputs and evidence

Operating Cash Flow: 170435000 USD Source
Operating Cash Flow: 150962000 USD Source
Capital Expenditure: 15809000 USD Source
Capital Expenditure: 11756000 USD Source

Cash and cash equivalents: 127 million USD 2020-09-30 Source
Exact value

126737000 USD
Long-term debt including current maturities: 585 million USD 2020-09-30 Source
Exact value

584902000 USD
Shares outstanding: 34.5 million shares 2020-09-30 Source
Exact value

34485827 shares

Reported share-count change

5.92% · 1.93 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

32559776 shares · 2019-09-30· Source
34485827 shares · 2020-09-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

814 million USD

2019-10-01 – 2020-09-30

Exact inputs and evidence

Revenue: 206079000 USD · 2019-10-01 – 2019-12-31 Source
Revenue: 193182000 USD · 2020-01-01 – 2020-03-31 Source
Revenue: 205148000 USD · 2020-04-01 – 2020-06-30 Source
Revenue: 209689000 USD · 2020-07-01 – 2020-09-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2020-11-06.

Financial data available through: 2019-12-31.

Coverage by financial measure

Revenue: 2 of 11 periods available· newest 2019-12-31
Operating income: 5 of 11 periods available· newest 2019-12-31
Net income: 5 of 11 periods available· newest 2019-12-31
Operating cash flow: 5 of 11 periods available· newest 2019-12-31
Capital expenditure: 5 of 11 periods available· newest 2019-12-31
Total assets: 2 of 11 periods available· newest 2019-12-31
Total liabilities: 2 of 11 periods available· newest 2019-12-31
Current assets: 2 of 11 periods available· newest 2019-12-31
Current liabilities: 2 of 11 periods available· newest 2019-12-31
Cash and cash equivalents: 2 of 11 periods available· newest 2019-12-31
Long-term debt including current maturities: 2 of 11 periods available· newest 2019-12-31
Shares outstanding: 2 of 11 periods available· newest 2019-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+2.1%

Prior period

USD 805.78 million

2018-01-01 – 2018-12-31
Current period

USD 822.52 million

2019-01-01 – 2019-12-31

Exact inputs and evidence

822522000 − 805776000 = 16746000 USD

805776000 USD · 2018-01-01 – 2018-12-31
Inspect prior input Prior source
822522000 USD · 2019-01-01 – 2019-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · American Renal Associates Holdings, Inc. · 2019-12-31 American Renal Associates Holdings, Inc. (edgar:1498068) Year-over-year change in Revenue: 16746000 USD Concept: fundies:Revenue Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: f2113abb6052e96113f9e8f055328dbb91fb9893b73c582950f9b346b109817e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1498068?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 822522000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1498068/000149806820000037/ara1231201910-kxdocume.htm#2293046 Filing: 000149806820000037 Input fundies:Revenue: 805776000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1498068/000149806820000037/ara1231201910-kxdocume.htm#2294046 Filing: 000149806820000037
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 14.98 million

Prior period

−USD 28.77 million

2018-01-01 – 2018-12-31
Current period

−USD 13.79 million

2019-01-01 – 2019-12-31

Exact inputs and evidence

-13790000 − -28767000 = 14977000 USD

-28767000 USD · 2018-01-01 – 2018-12-31
Inspect prior input Prior source
-13790000 USD · 2019-01-01 – 2019-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · American Renal Associates Holdings, Inc. · 2019-12-31 American Renal Associates Holdings, Inc. (edgar:1498068) Year-over-year change in Net income: 14977000 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: f2113abb6052e96113f9e8f055328dbb91fb9893b73c582950f9b346b109817e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1498068?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -13790000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1498068/000149806820000037/ara1231201910-kxdocume.htm#3767830 Filing: 000149806820000037 Input fundies:NetIncome: -28767000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1498068/000149806820000037/ara1231201910-kxdocume.htm#3769081 Filing: 000149806820000037
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
-63.5%

Prior period

USD 106.4 million

2018-01-01 – 2018-12-31
Current period

USD 38.82 million

2019-01-01 – 2019-12-31

Exact inputs and evidence

38821000 − 106404000 = -67583000 USD

106404000 USD · 2018-01-01 – 2018-12-31
Inspect prior input Prior source
38821000 USD · 2019-01-01 – 2019-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · American Renal Associates Holdings, Inc. · 2019-12-31 American Renal Associates Holdings, Inc. (edgar:1498068) Year-over-year change in Operating cash flow: -67583000 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: f2113abb6052e96113f9e8f055328dbb91fb9893b73c582950f9b346b109817e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1498068?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: 38821000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1498068/000149806820000037/ara1231201910-kxdocume.htm#2804077 Filing: 000149806820000037 Input fundies:OperatingCashFlow: 106404000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1498068/000149806820000037/ara1231201910-kxdocume.htm#2805127 Filing: 000149806820000037
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-48.6%

Prior period

USD 44.96 million

2018-01-01 – 2018-12-31
Current period

USD 23.12 million

2019-01-01 – 2019-12-31

Exact inputs and evidence

23122000 − 44960000 = -21838000 USD

44960000 USD · 2018-01-01 – 2018-12-31
Inspect prior input Prior source
23122000 USD · 2019-01-01 – 2019-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · American Renal Associates Holdings, Inc. · 2019-12-31 American Renal Associates Holdings, Inc. (edgar:1498068) Year-over-year change in Capital expenditure: -21838000 USD Concept: fundies:CapitalExpenditure Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: f2113abb6052e96113f9e8f055328dbb91fb9893b73c582950f9b346b109817e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1498068?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 23122000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1498068/000149806820000037/ara1231201910-kxdocume.htm#2809082 Filing: 000149806820000037 Input fundies:CapitalExpenditure: 44960000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1498068/000149806820000037/ara1231201910-kxdocume.htm#2810062 Filing: 000149806820000037
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2019 2019-01-01 – 2019-12-31

Revenue USD 822.52 million 100% of revenue
Operating costs Derived USD 770.85 million 94% of revenue
Operating income USD 51.67 million 6.3% of revenue
Tax, interest and other Derived USD 65.46 million 8% of revenue
Net income −USD 13.79 million −1.7% of revenue

Cash

Operating cash flow USD 38.82 million 4.7% of revenue
Capital expenditure USD 23.12 million 2.8% of revenue
Free cash flow Derived USD 15.7 million 1.9% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2018 Net loss: net income was −3.6% of revenue.
2019 Net loss: net income was −1.7% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2018 2018-01-01 – 2018-12-31	805776000	750454000 Derived	55322000	84089000 Derived	-28767000	61444000 Derived	Source 2018-01-01 – 2018-12-31: 805776000 USD Inspect Revenue Open source 2018-01-01 – 2018-12-31: 55322000 USD Inspect Operating Income Open source 2018-01-01 – 2018-12-31: -28767000 USD Inspect Net Income Open source 2018-01-01 – 2018-12-31: 106404000 USD Inspect Operating Cash Flow Open source 2018-01-01 – 2018-12-31: 44960000 USD Inspect Capital Expenditure Open source
2019 2019-01-01 – 2019-12-31	822522000	770849000 Derived	51673000	65463000 Derived	-13790000	15699000 Derived	Source 2019-01-01 – 2019-12-31: 822522000 USD Inspect Revenue Open source 2019-01-01 – 2019-12-31: 51673000 USD Inspect Operating Income Open source 2019-01-01 – 2019-12-31: -13790000 USD Inspect Net Income Open source 2019-01-01 – 2019-12-31: 38821000 USD Inspect Operating Cash Flow Open source 2019-01-01 – 2019-12-31: 23122000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 822.5M 2019

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20182018-12-31	Revenue	805776000	Revenue: 805776000 Open source
20192019-12-31	Revenue	822522000	Revenue: 822522000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

2.1% 2019

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20182018-12-31	Year over year	No prior comparable period	Revenue: 805776000 Open source
20192019-12-31	Year over year	2.1%	Revenue: 822522000 Open source Revenue: 805776000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin 6.3% 2019

Net margin -1.7% 2019

Free cash flow margin 1.9% 2019

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20182018-12-31	Operating margin	6.9%	Operating Income: 55322000 Open source Revenue: 805776000 Open source
20192019-12-31	Operating margin	6.3%	Operating Income: 51673000 Open source Revenue: 822522000 Open source
20182018-12-31	Net margin	-3.6%	Net Income: -28767000 Open source Revenue: 805776000 Open source
20192019-12-31	Net margin	-1.7%	Net Income: -13790000 Open source Revenue: 822522000 Open source
20182018-12-31	Free cash flow margin	7.6%	Revenue: 805776000 Open source Operating Cash Flow: 106404000 Open source Capital Expenditure: 44960000 Open source
20192019-12-31	Free cash flow margin	1.9%	Revenue: 822522000 Open source Operating Cash Flow: 38821000 Open source Capital Expenditure: 23122000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD 38.8M 2019

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20182018-12-31	Operating cash flow	106404000	Operating Cash Flow: 106404000 Open source
20192019-12-31	Operating cash flow	38821000	Operating Cash Flow: 38821000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD 15.7M 2019

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20182018-12-31	Free cash flow	61444000	Operating Cash Flow: 106404000 Open source Capital Expenditure: 44960000 Open source
20192019-12-31	Free cash flow	15699000	Operating Cash Flow: 38821000 Open source Capital Expenditure: 23122000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

80.6% 2019

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20182018-12-31	Liabilities / assets	75.8%	Total Liabilities: 746833000 Open source Total Assets: 985843000 Open source
20192019-12-31	Liabilities / assets	80.6%	Total Liabilities: 875769000 Open source Total Assets: 1086791000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

1.15× 2019

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20182018-12-31	Current assets / current liabilities	0.99×	Current Assets: 194863000 Open source Current Liabilities: 197640000 Open source
20192019-12-31	Current assets / current liabilities	1.15×	Current Assets: 220014000 Open source Current Liabilities: 190935000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2015 2015-01-01 – 2015-12-31	USD 18.85 million Exact value Exact value: 18845000 USD 2015-01-01 – 2015-12-31: 18845000 USD Inspect Net Income Open source Share or cite Citation for Net Income · American Renal Associates Holdings, Inc. · 2015-12-31 American Renal Associates Holdings, Inc. (edgar:1498068) Net Income: 18845000 USD Concept: fundies:NetIncome Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: f2113abb6052e96113f9e8f055328dbb91fb9893b73c582950f9b346b109817e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1498068/explain?concept=fundies%3ANetIncome&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:NetIncome: 18845000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1498068/000149806818000012/ara-20171231.xml#315894 Filing: 000149806818000012 The citation records this snapshot. The page link may show a newer release later.	USD 133.6 million Exact value Exact value: 133595000 USD 2015-01-01 – 2015-12-31: 133595000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · American Renal Associates Holdings, Inc. · 2015-12-31 American Renal Associates Holdings, Inc. (edgar:1498068) Operating Cash Flow: 133595000 USD Concept: fundies:OperatingCashFlow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: f2113abb6052e96113f9e8f055328dbb91fb9893b73c582950f9b346b109817e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1498068/explain?concept=fundies%3AOperatingCashFlow&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 133595000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1498068/000149806818000012/ara-20171231.xml#315258 Filing: 000149806818000012 The citation records this snapshot. The page link may show a newer release later.	USD 46.27 million Exact value Exact value: 46273000 USD 2015-01-01 – 2015-12-31: 46273000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · American Renal Associates Holdings, Inc. · 2015-12-31 American Renal Associates Holdings, Inc. (edgar:1498068) Capital Expenditure: 46273000 USD Concept: fundies:CapitalExpenditure Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: f2113abb6052e96113f9e8f055328dbb91fb9893b73c582950f9b346b109817e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1498068/explain?concept=fundies%3ACapitalExpenditure&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 46273000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1498068/000149806818000012/ara-20171231.xml#341302 Filing: 000149806818000012 The citation records this snapshot. The page link may show a newer release later.	USD 87.32 million Calculation and evidence 133595000 − 46273000 USD Exact free cash flow: 87322000 USD 2015-01-01 – 2015-12-31: 133595000 USD · Inspect Operating Cash Flow · Source 2015-01-01 – 2015-12-31: 46273000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · American Renal Associates Holdings, Inc. · 2015-12-31 American Renal Associates Holdings, Inc. (edgar:1498068) Free cash flow: 87322000 USD Concept: free-cash-flow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: f2113abb6052e96113f9e8f055328dbb91fb9893b73c582950f9b346b109817e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1498068?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 133595000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1498068/000149806818000012/ara-20171231.xml#315258 Filing: 000149806818000012 Input fundies:CapitalExpenditure: 46273000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1498068/000149806818000012/ara-20171231.xml#341302 Filing: 000149806818000012 The citation records this snapshot. The page link may show a newer release later.
2016 2016-01-01 – 2016-12-31	USD 3.15 million Exact value Exact value: 3146000 USD 2016-01-01 – 2016-12-31: 3146000 USD Inspect Net Income Open source Share or cite Citation for Net Income · American Renal Associates Holdings, Inc. · 2016-12-31 American Renal Associates Holdings, Inc. (edgar:1498068) Net Income: 3146000 USD Concept: fundies:NetIncome Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: f2113abb6052e96113f9e8f055328dbb91fb9893b73c582950f9b346b109817e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1498068/explain?concept=fundies%3ANetIncome&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:NetIncome: 3146000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1498068/000149806819000060/ara-20181231.xml#1000052 Filing: 000149806819000060 The citation records this snapshot. The page link may show a newer release later.	USD 172.21 million Exact value Exact value: 172206000 USD 2016-01-01 – 2016-12-31: 172206000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · American Renal Associates Holdings, Inc. · 2016-12-31 American Renal Associates Holdings, Inc. (edgar:1498068) Operating Cash Flow: 172206000 USD Concept: fundies:OperatingCashFlow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: f2113abb6052e96113f9e8f055328dbb91fb9893b73c582950f9b346b109817e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1498068/explain?concept=fundies%3AOperatingCashFlow&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 172206000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1498068/000149806819000060/ara-20181231.xml#991107 Filing: 000149806819000060 The citation records this snapshot. The page link may show a newer release later.	USD 61.43 million Exact value Exact value: 61432000 USD 2016-01-01 – 2016-12-31: 61432000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · American Renal Associates Holdings, Inc. · 2016-12-31 American Renal Associates Holdings, Inc. (edgar:1498068) Capital Expenditure: 61432000 USD Concept: fundies:CapitalExpenditure Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: f2113abb6052e96113f9e8f055328dbb91fb9893b73c582950f9b346b109817e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1498068/explain?concept=fundies%3ACapitalExpenditure&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 61432000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1498068/000149806819000060/ara-20181231.xml#1123875 Filing: 000149806819000060 The citation records this snapshot. The page link may show a newer release later.	USD 110.77 million Calculation and evidence 172206000 − 61432000 USD Exact free cash flow: 110774000 USD 2016-01-01 – 2016-12-31: 172206000 USD · Inspect Operating Cash Flow · Source 2016-01-01 – 2016-12-31: 61432000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · American Renal Associates Holdings, Inc. · 2016-12-31 American Renal Associates Holdings, Inc. (edgar:1498068) Free cash flow: 110774000 USD Concept: free-cash-flow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: f2113abb6052e96113f9e8f055328dbb91fb9893b73c582950f9b346b109817e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1498068?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 172206000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1498068/000149806819000060/ara-20181231.xml#991107 Filing: 000149806819000060 Input fundies:CapitalExpenditure: 61432000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1498068/000149806819000060/ara-20181231.xml#1123875 Filing: 000149806819000060 The citation records this snapshot. The page link may show a newer release later.
2017 2017-01-01 – 2017-12-31	−USD 4.6 million Exact value Exact value: -4597000 USD 2017-01-01 – 2017-12-31: -4597000 USD Inspect Net Income Open source Share or cite Citation for Net Income · American Renal Associates Holdings, Inc. · 2017-12-31 American Renal Associates Holdings, Inc. (edgar:1498068) Net Income: -4597000 USD Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: f2113abb6052e96113f9e8f055328dbb91fb9893b73c582950f9b346b109817e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1498068/explain?concept=fundies%3ANetIncome&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:NetIncome: -4597000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1498068/000149806820000037/ara1231201910-kxdocume.htm#3770332 Filing: 000149806820000037 The citation records this snapshot. The page link may show a newer release later.	USD 128.55 million Exact value Exact value: 128548000 USD 2017-01-01 – 2017-12-31: 128548000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · American Renal Associates Holdings, Inc. · 2017-12-31 American Renal Associates Holdings, Inc. (edgar:1498068) Operating Cash Flow: 128548000 USD Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: f2113abb6052e96113f9e8f055328dbb91fb9893b73c582950f9b346b109817e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1498068/explain?concept=fundies%3AOperatingCashFlow&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 128548000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1498068/000149806820000037/ara1231201910-kxdocume.htm#2806178 Filing: 000149806820000037 The citation records this snapshot. The page link may show a newer release later.	USD 36.07 million Exact value Exact value: 36073000 USD 2017-01-01 – 2017-12-31: 36073000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · American Renal Associates Holdings, Inc. · 2017-12-31 American Renal Associates Holdings, Inc. (edgar:1498068) Capital Expenditure: 36073000 USD Concept: fundies:CapitalExpenditure Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: f2113abb6052e96113f9e8f055328dbb91fb9893b73c582950f9b346b109817e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1498068/explain?concept=fundies%3ACapitalExpenditure&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 36073000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1498068/000149806820000037/ara1231201910-kxdocume.htm#2811042 Filing: 000149806820000037 The citation records this snapshot. The page link may show a newer release later.	USD 92.48 million Calculation and evidence 128548000 − 36073000 USD Exact free cash flow: 92475000 USD 2017-01-01 – 2017-12-31: 128548000 USD · Inspect Operating Cash Flow · Source 2017-01-01 – 2017-12-31: 36073000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · American Renal Associates Holdings, Inc. · 2017-12-31 American Renal Associates Holdings, Inc. (edgar:1498068) Free cash flow: 92475000 USD Concept: free-cash-flow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: f2113abb6052e96113f9e8f055328dbb91fb9893b73c582950f9b346b109817e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1498068?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 128548000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1498068/000149806820000037/ara1231201910-kxdocume.htm#2806178 Filing: 000149806820000037 Input fundies:CapitalExpenditure: 36073000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1498068/000149806820000037/ara1231201910-kxdocume.htm#2811042 Filing: 000149806820000037 The citation records this snapshot. The page link may show a newer release later.
2018 2018-01-01 – 2018-12-31	−USD 28.77 million Exact value Exact value: -28767000 USD 2018-01-01 – 2018-12-31: -28767000 USD Inspect Net Income Open source Share or cite Citation for Net Income · American Renal Associates Holdings, Inc. · 2018-12-31 American Renal Associates Holdings, Inc. (edgar:1498068) Net Income: -28767000 USD Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: f2113abb6052e96113f9e8f055328dbb91fb9893b73c582950f9b346b109817e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1498068/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:NetIncome: -28767000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1498068/000149806820000037/ara1231201910-kxdocume.htm#3769081 Filing: 000149806820000037 The citation records this snapshot. The page link may show a newer release later.	USD 106.4 million Exact value Exact value: 106404000 USD 2018-01-01 – 2018-12-31: 106404000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · American Renal Associates Holdings, Inc. · 2018-12-31 American Renal Associates Holdings, Inc. (edgar:1498068) Operating Cash Flow: 106404000 USD Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: f2113abb6052e96113f9e8f055328dbb91fb9893b73c582950f9b346b109817e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1498068/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 106404000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1498068/000149806820000037/ara1231201910-kxdocume.htm#2805127 Filing: 000149806820000037 The citation records this snapshot. The page link may show a newer release later.	USD 44.96 million Exact value Exact value: 44960000 USD 2018-01-01 – 2018-12-31: 44960000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · American Renal Associates Holdings, Inc. · 2018-12-31 American Renal Associates Holdings, Inc. (edgar:1498068) Capital Expenditure: 44960000 USD Concept: fundies:CapitalExpenditure Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: f2113abb6052e96113f9e8f055328dbb91fb9893b73c582950f9b346b109817e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1498068/explain?concept=fundies%3ACapitalExpenditure&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 44960000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1498068/000149806820000037/ara1231201910-kxdocume.htm#2810062 Filing: 000149806820000037 The citation records this snapshot. The page link may show a newer release later.	USD 61.44 million Calculation and evidence 106404000 − 44960000 USD Exact free cash flow: 61444000 USD 2018-01-01 – 2018-12-31: 106404000 USD · Inspect Operating Cash Flow · Source 2018-01-01 – 2018-12-31: 44960000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · American Renal Associates Holdings, Inc. · 2018-12-31 American Renal Associates Holdings, Inc. (edgar:1498068) Free cash flow: 61444000 USD Concept: free-cash-flow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: f2113abb6052e96113f9e8f055328dbb91fb9893b73c582950f9b346b109817e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1498068?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 106404000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1498068/000149806820000037/ara1231201910-kxdocume.htm#2805127 Filing: 000149806820000037 Input fundies:CapitalExpenditure: 44960000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1498068/000149806820000037/ara1231201910-kxdocume.htm#2810062 Filing: 000149806820000037 The citation records this snapshot. The page link may show a newer release later.
2019 2019-01-01 – 2019-12-31	−USD 13.79 million Exact value Exact value: -13790000 USD 2019-01-01 – 2019-12-31: -13790000 USD Inspect Net Income Open source Share or cite Citation for Net Income · American Renal Associates Holdings, Inc. · 2019-12-31 American Renal Associates Holdings, Inc. (edgar:1498068) Net Income: -13790000 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: f2113abb6052e96113f9e8f055328dbb91fb9893b73c582950f9b346b109817e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1498068/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:NetIncome: -13790000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1498068/000149806820000037/ara1231201910-kxdocume.htm#3767830 Filing: 000149806820000037 The citation records this snapshot. The page link may show a newer release later.	USD 38.82 million Exact value Exact value: 38821000 USD 2019-01-01 – 2019-12-31: 38821000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · American Renal Associates Holdings, Inc. · 2019-12-31 American Renal Associates Holdings, Inc. (edgar:1498068) Operating Cash Flow: 38821000 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: f2113abb6052e96113f9e8f055328dbb91fb9893b73c582950f9b346b109817e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1498068/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 38821000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1498068/000149806820000037/ara1231201910-kxdocume.htm#2804077 Filing: 000149806820000037 The citation records this snapshot. The page link may show a newer release later.	USD 23.12 million Exact value Exact value: 23122000 USD 2019-01-01 – 2019-12-31: 23122000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · American Renal Associates Holdings, Inc. · 2019-12-31 American Renal Associates Holdings, Inc. (edgar:1498068) Capital Expenditure: 23122000 USD Concept: fundies:CapitalExpenditure Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: f2113abb6052e96113f9e8f055328dbb91fb9893b73c582950f9b346b109817e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1498068/explain?concept=fundies%3ACapitalExpenditure&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 23122000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1498068/000149806820000037/ara1231201910-kxdocume.htm#2809082 Filing: 000149806820000037 The citation records this snapshot. The page link may show a newer release later.	USD 15.7 million Calculation and evidence 38821000 − 23122000 USD Exact free cash flow: 15699000 USD 2019-01-01 – 2019-12-31: 38821000 USD · Inspect Operating Cash Flow · Source 2019-01-01 – 2019-12-31: 23122000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · American Renal Associates Holdings, Inc. · 2019-12-31 American Renal Associates Holdings, Inc. (edgar:1498068) Free cash flow: 15699000 USD Concept: free-cash-flow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: f2113abb6052e96113f9e8f055328dbb91fb9893b73c582950f9b346b109817e Dimensions: Consolidated View: https://fundies.io/companies/edgar/1498068?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 38821000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1498068/000149806820000037/ara1231201910-kxdocume.htm#2804077 Filing: 000149806820000037 Input fundies:CapitalExpenditure: 23122000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1498068/000149806820000037/ara1231201910-kxdocume.htm#2809082 Filing: 000149806820000037 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

23 filings · 2,154 latest values · 2,154 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001498068, 1498068, ARA, edgar:1498068

Also known as American Renal Associates Holdings, Inc., C.P. Atlas Holdings, Inc.

American Renal Associates Holdings, Inc.

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Reported share-count change

Trailing twelve months

Revenue

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2019 2019-01-01 – 2019-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation